Patents Assigned to Pinteon Therapeutics Inc.
  • METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF HUMANIZED CONFORMATION-SPECIFIC PHOSPHORYLATED TAU ANTIBODIES
    Publication number: 20230287093
    Abstract: The present disclosure relates generally to conformation-specific antibodies that can bind to and neutralize the activity of phosphorylated-Threonine 231-tau protein (pT231-tau). The antibodies of the present technology are useful in methods for treating a neurological disorder associated with elevated cis-pT231-tau protein expression in a subject in need thereof.
    Type: Application
    Filed: January 17, 2023
    Publication date: September 14, 2023
    Applicant: Pinteon Therapeutics Inc.
    Inventors: Shankar Kumar, Naoya Tsurushita, Michael Ahlijanian, Martin Jefson
  • Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
    Patent number: 11591385
    Abstract: The present disclosure relates generally to conformation-specific antibodies that can bind to and neutralize the activity of phosphorylated-Threonine 231-tau protein (pT231-tau). The antibodies of the present technology are useful in methods for treating a neurological disorder associated with elevated cis-pT231-tau protein expression in a subject in need thereof.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: February 28, 2023
    Assignee: Pinteon Therapeutics Inc.
    Inventors: Shankar Kumar, Naoya Tsurushita, Michael Ahlijanian, Martin Jefson
  • METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF HUMANIZED CONFORMATION-SPECIFIC PHOSPHORYLATED TAU ANTIBODIES
    Publication number: 20200362022
    Abstract: The present disclosure relates generally to conformation-specific antibodies that can bind to and neutralize the activity of phosphorylated-Threonine 231-tau protein (pT231-tau). The antibodies of the present technology are useful in methods for treating a neurological disorder associated with elevated cis-pT231-tau protein expression in a subject in need thereof.
    Type: Application
    Filed: November 8, 2018
    Publication date: November 19, 2020
    Applicant: Pinteon Therapeutics Inc.
    Inventors: Shankar KUMAR, Naoya Tsurushita, Michael Ahlijanian, Martin JEFSON